Military Medicine in Iraq

 Doctors get a lot of flak these days without ever going near a battle zone. They are bombarded with accusations of not caring about their patients, of being shills for Big Pharma, of being motivated by money, of killing patients with medical errors and drug side effects. In addition, they are bombarded with claims that non-scientific medical systems (so-called alternative medicine, from chiropractic to Ayurveda) offer greater benefits to patients. 

It was a delight to read a new book   about a doctor who was exposed to real flak in Iraq. His story is a wonderful reminder of how effective modern medicine is and it is an eye-opener about the selfless dedication of doctors who put themselves in harm’s way; who accept lower incomes, separation from families, and poor living conditions; who care desperately about their patients; and who magnanimously apply the same skills to treating friend and foe. 

The title is Coppola: A Pediatric Surgeon in Iraq. The author, Chris Coppola, is an Air Force pediatric surgeon who was twice deployed to Balad Air Base, 50 miles north of Baghdad, as a trauma surgeon. In his first night on call, he treats the five worst gunshot injuries he has ever seen – and they are all in the same patient! Despite serious damage to liver, colon, small intestine, pancreas, duodenum, vena cava and spine, the patient, a 22 year old Iraqi policeman, recovers. As the foreword of the book explains, the survival rate for troops injured in the field was 20% in WWI, 40% in WWII, 66% in Viet Nam, and is now an astounding 97% in Iraq. Lessons learned in war are translated to civilian trauma care and we all benefit from the knowledge however much we may deplore the war. 

No subluxations were adjusted, no qi manipulated, no acupuncture points stimulated, no homeopathic or herbal medicines given. Beside numbers like these, alternative medicine looks pretty puny and irrelevant. And the Air Force’s initiative to train doctors in battlefield acupuncture looks frankly delusional. 

Coppola is in Iraq during the first elections. An elderly woman is the victim of an IED (Improvised Explosive Device) detonated near a line of people waiting to vote. As they prepare her for surgery to stabilize her broken bones, she proudly holds up her right index finger with the purple ink stain showing she voted. They also treat a 17 year old girl who was shot in the neck at a polling place and will likely never walk again. They treat a small child with a skull fractured by shrapnel while waiting with his father in a voting line. Children are particularly at risk from IEDs: their heads are proportionately larger and they are closer to the ground. 

They treat an insurgent whose bomb detonated prematurely. He is a would-be murderer, but all Coppola sees is “a dying man who needs our treatment.” 

He has to work through translators. Cultural differences intrude as he tries to explain to a father that his baby “boy” is really a girl with an intersex condition. Such a child would be raised as a girl in the US, but the Iraqi father violently objects to that option because of cultural prejudice against females. 

They treat many Iraqi citizens and are worried when they release them because they are not likely to get adequate follow-up care. The Iraqi medical system has been devastated: doctors have fled, supplies are impossible to get. The Iraqis are not taxed: the government is funded only by oil sales and foreign aid. They do colostomies meant to be temporary but know it is unlikely their patients will ever be able to get the colostomies taken down. They see Iraqis with soiled towels wrapped around their colostomies because they can’t get colostomy bags. When a colleague wonders if they should send a patient to a burn facility, he is told “We are the burn facility in Iraq.” 

The Iraqi children he treats are small for their age and malnourished. Nutritious food is part of the medical treatment. They discover that a Kurdish refugee boy is only taking a few bites of his meals and hoarding the rest to take home to his family. They persuade him to eat by offering him Oreos and enough other donations from their own care packages to fill two large bags to take home. 

Coppola paints a vivid picture of deployed life: eating MREs (Meals Ready to Eat), jogging with 35 pounds of body armor and other protective equipment, suffering through the “hurry up and wait” military hassles, having to wear a gun in the OR during alerts, taking cover from incoming missiles, desperately missing his family. There is a signpost with the distance to various cities around the world, topped by a sign “Hell – 0 miles.” And yet he is more than willing to go back for a second deployment because he knows how badly he is needed. 

He treats casualties from the battle at Abu Ghraib prison, where prisoners and insurgents mounted a coordinated attack on the guards. Iraqis tell him they were not surprised to learn that prisoners had been tortured by Americans. They assumed that torture was being used – torture had always been a part of that prison, and far worse had happened under Saddam Hussein, attested to by the adjacent mass graves. Not that that’s any excuse. 

By his second tour, the patient population had changed. After the troop surge, Al Qaeda was no longer so brave about attacking Americans; now they concentrated on civilian targets, even including schools. Instead of American and Iraqi soldiers, now most of their patients are civilians and 1/3 of them are children. 

One of the most affecting stories in the book is that of Leila, a little girl who was extensively burned by an incendiary bomb thrown into her home. Her father was an Iraqi officer who had been successfully subduing the insurgents in his area and this was an act of revenge. Coppola is doing a complicated skin graft procedure on Leila when an emergency intervenes to commandeer his OR; he has to improvise to save the grafts and free up the OR as soon as possible. He treats her tenderly for a couple of months and is devastated when she eventually dies of a complicating infection. Later an Iraqi adult patient is taken away by guards. Coppola learns that that patient was the one who had thrown the firebomb into Leila’s house – and the American hospital had saved his life. And he later learns that Leila’s father is killed by insurgents. 

Another detainee is ungrateful even after several life-saving operations. He only speaks to repeatedly vow to shoot them all. 

Coppola is in the OR during a Christmas USO show with Robin Williams, Lance Armstrong, Miss USA, Kid Rock, Lewis Black and other celebrities. He is sorry that he missed the concert but says he couldn’t have enjoyed it knowing a child was waiting to be operated on. He says, “Each new injured child I see seems to rip the scab off a wound in my heart that won’t let me rest.” One of the reasons he chose surgery over pediatrics is that he is so distressed when he has to cause pain to an awake child. 

Coppola accepted an Air Force scholarship and advanced training that obligated him to 6 years of pay-back service. He points out that this meant a financial disadvantage. In 3 years in private practice he could have paid off any medical school debts and still have had a greater income than his Air Force salary for 6 years. He joined the Air Force because he wanted to serve his country. He went to Iraq because he had signed a contract and was obligated to go wherever they sent him.  Some of his colleagues supported the war, some did not, but they were all there to save lives. All were volunteers. 

One word kept running through my mind as I read this book. It is a word seldom used these days. The word is “honor.”


[Slashdot]
[Digg]
[Reddit]
[del.icio.us]
[Facebook]
[Technorati]
[Google]
[StumbleUpon]

A Not-So-Split Decision

For those who battle tirelessly against the never ending onslaught of anti-vaccine propaganda, misinformation, and fear, there was great news the other day from Merck. The pharmaceutical company, and maker of the MMR vaccine against measles, mumps, and rubella, has decided not to resume production of the individual, or “split”, components of the vaccine. A Merck representative made the announcement during a meeting of the CDC Advisory Committee on Immunization Practices (ACIP) on Tuesday. During previous ACIP meetings, science experts on that committee presented compelling arguments against  continued, large scale production of the monovalent components of the MMR vaccine, which were echoed by scientists in Merck’s vaccine division. In a moment, I’ll discuss the arguments against the split vaccine, and why this is so important a decision. First, some background on the issue of splitting the MMR.

Merck has manufactured individual measles, mumps, and rubella vaccines on a small scale for various reasons. For example, the monovalent measles vaccine has been recommended during measles epidemics to protect infants 6-12 months of age from infection, and rubella vaccine is given to women without immunity, to protect against congenital rubella syndrome in future pregnancies. But since 1967, the MMR vaccine has been the primary source of protection against measles, mumps, and congenital rubella. The  original recommendation for the use of the combination vaccine at 12 months of age, and the recommendation in 1989 to add a booster dose at 4-6 years, has led to the near eradication of these diseases in the US. But in 1998, the infamous Andrew Wakefield warned the public to avoid the MMR vaccine, and instead opt for the monovalent components, spread out over time. This announcement came during a press conference to announce his also infamous, and thoroughly discredited Lancet paper linking the MMR vaccine to autism. It came as a shock to all of us who understand the importance of the MMR vaccine, and who know of no scientific rationale to split the vaccine. Wakefield claimed he had reason to believe the combined vaccine might lead to autism in some children. Of course, his reason was not based on any scientific evidence, and we now know that he had an undisclosed financial incentive to push people toward a monovalent measles vaccine. To this date, not a single shred of science supports the notion that the MMR vaccine causes autism, nor are there any scientifically plausible reasons that it would. As we know, mountains of data point to just the opposite conclusion. Despite absolutely no scientific rationale for splitting the MMR vaccine, and despite the fact that all of Wakefield’s claims about the MMR vaccine and autism have been thoroughly debunked, the myth lives on. I am still confronted by parents who are worried about the vaccine, and who request, or at least ask about, splitting the vaccine. On my local parents list-serve, the issue constantly rears its head, and each time I attempt to step in to reassure and educate, I am met with a wall of fear and opposition. Because of this irrational fear, pockets of unimmunized children have set the stage for disease outbreaks, and have already led to outbreaks around the country. Just this week I received an alert from the NYS DOH about a mumps outbreak in my own backyard, similar to an alert in July about a measles outbreak. Unbelievably, this doesn’t seem to phase the many parents who have fallen victim to the growing epidemic of vaccine fear.

There are several reasons Merck’s decision about the MMR vaccine is so important. In addition to creating the need for more doctor visits, with more shots, more pain, and at greater cost, splitting the vaccine into individual components prolongs the vaccination process (each component must be separated by at least a month to insure efficacy), increasing a child’s vulnerability to disease. Administration of separate components over prolonged intervals is also less likely to result in completion of the series, than is administration of a single vaccine. But perhaps more importantly, this decision is a vote against irrationality and an anti-scientific worldview that has begun to endanger society. Many parents will be upset and disappointed by Merck’s decision, especially those who were just recently reassured by Dr. Sears that Merck was poised to reintroduce the separate components in 2011. The fact is, this was actually a bad decision for Merck from a purely economic perspective. It costs considerably more to manufacture, produce, and test combination vaccines than monovalent vaccines.  Selling three individual components would also produce more revenue than a single combination product. Nevertheless, the anti-vaccine lobby will most assuredly find a way to paint this decision as a picture of government-industry conspiracy, intent on covering up the truth and depriving parents of a safer choice. One could say “you never win”, but for now I’m just happy we did.


[Slashdot]
[Digg]
[Reddit]
[del.icio.us]
[Facebook]
[Technorati]
[Google]
[StumbleUpon]

A science-based blog about GMO

Much time, money, and ink is spent in our culture obsessing over what foods are “good” or “bad” for health. Oftentimes such claims are out of proportion with available evidence, perhaps based on reasonable-sounding theories but not so much on convincing data. Here are a few examples of SBM bloggers addressing food and diet: 1, 2, 3, 4.

An interesting subset of food claims relate to the safety of genetically modified organisms (GMO) in the food chain, safety both for individuals and for ecosystems. I’d like to recommend SBM readers to a blog called Biofortified written by graduate students and scientists in plant genetics. The Biofortified bloggers explain hot topics and controversies in genetic engineering, attempting to cut through the wild propoganda in favor of calm science. The authors tend to be more pro-GMO than not—perhaps unsurprising since their careers are spent studying them—but they strike me as quite reasonable in their support. Here are a few posts I liked: on fears about GE crops, on food labels, on anecdotal health claims, on gene patents, on smoking your vaccines someday.

Today is a particularly good time for you to check out Biofortified because they are competing in the Ashoka Changemakers “GMO: Risk or Rescue?” contest. According to Karl, a grad student who writes on Biofortified, theirs is the only “pro-science” group in the running. The prize includes a nice grant and an opportunity to have a conversation with author Michael Pollan. If you like the blog enough to vote for them by this Wednesday 10/28 at 6pm EST, see details about the contest here.


[Slashdot]
[Digg]
[Reddit]
[del.icio.us]
[Facebook]
[Technorati]
[Google]
[StumbleUpon]

Suzanne Somers’ Knockout: Dangerous misinformation about cancer (part 1)

If there’s one thing I’ve become utterly disgusted with in the time since I first became interested in science-based medicine as a concept, its promotion, and the refutation of quackery and medical pseudoscience, it’s empty-brained celebrities with an agenda. Be it from imbibing the atmosphere within the bubble of woo-friendly southern California or taking a crash course at the University of Google and, through the arrogance of ignorance, concluding that they know more than scientists who have devoted their lives to studying a problem, celebrities believing in and credulously promoting pseudoscience present a special problem because of the oversized soapboxes they command. Examples abound. There’s Bill Maher promoting anti-vaccine pseudoscience, germ theory denialism, and cancer quackery on his show Real Time with Bill Maher and getting the Richard Dawkins Award from the Atheist Alliance International in spite of his antiscience stances on vaccines and what he sneeringly calls “Western medicine.” Then there are, of course, the current public faces of the anti-vaccine movement, Jenny McCarthy and her boyfriend Jim Carrey, the former of whom thinks it’s just hunky dory (or at least doesn’t appear to be the least bit troubled) that her efforts are contributing to the return of vaccine-preventable infectious diseases because she apparently thinks that’s what it will take to make the pharmaceutical companies change their “shit” product (her words), and the latter of whom spreads conspiracy theories about vaccines and contempt on people suffering from restless leg syndrome. Finally, there’s the grand macher of celebrity woo promotion, Oprah Winfrey, who routinely promotes all manner of medical pseudoscience, be it “bioidentical” hormones, the myth that vaccines cause autism (even hiring Jenny McCarthy to do a blog and develop a talk show for her company Harpo Productions), or other nonsense, such as Christiane Northrup urging Oprah viewers to focus their qi to their vaginas for better sex.

Unfortunately, last week the latest celebrity know-nothing to promote health misinformation released a brand new book and has been all over the airwaves, including The Today Show, Larry King Live, and elsewhere promoting it. Yes, I’m talking about Suzanne Somers, formerly known for her testimonial of having “rejected chemotherapy and tamoxifen” for her breast cancer, as well as her promotion of “bioidentical hormones,” various exercise devices such as the Thighmaster and all manner of supplements. Her book is entitled Knockout: Interviews with Doctors Who Are Curing Cancer–And How to Prevent Getting It in the First Place. It is described on the Random House website thusly:

In Knockout, Suzanne Somers interviews doctors who are successfully using the most innovative cancer treatments–treatments that build up the body rather than tear it down. Somers herself has stared cancer in the face, and a decade later she has conquered her fear and has emerged confident with the path she’s chosen.

Now she shares her personal choices and outlines an array of options from doctors across the country:

EFFECTIVE ALTERNATIVE TREATMENTS

  • without chemotherapy
  • without radiation
  • sometimes, even without surgery

INTEGRATIVE PROTOCOLS

  • combining standard treatments with therapies that build up the immune system

METHODS FOR MANAGING CANCER

  • outlining ways to truly live with the diease

Since prevention is the best course, Somers’ experts provide nutrition, lifestyle, and dietary supplementation options to help protect you from getting the disease in the first place. Whichever path you choose, Knockout is a must-have resource to navigate the life-and-death world of cancer and increase your odds of survival. After reading stunning testimonials from inspirational survivors using alternative treatments, you’ll be left with a feeling of empowerment and something every person who is touched by this disease needs…HOPE.

I first found out about Somers’ book about a month and a half ago and was fortunate enough (I think) that one of my readers who had a review copy of the book sent me a chapter list. The reason I wanted a chapter list was because I was really curious just who these doctors were whom Somers had interviewed. In particular, back then I predicted (and hoped) that one of the doctors would be one whom we’ve met before. It was. Can you guess which one? Think about it. What major study did I blog about in the middle of September? What form of cancer quackery has been covered so ably by Kimball Atwood since the very beginning of this blog? No, no, you don’t have to go back to the archives and search. I’ll tell you:

Dr. Nicholas Gonzalez. He’s the second featured doctor who is “curing cancer,” right there in Somers’ book in Chapter 6!

That’s right, one of these doctors who are “curing cancer” is a quack (in my opinion, of course) whose “protocol,” which includes 150 supplement pills a day topped off by a couple of coffee enemas per day, was recently shown to be worse than useless for pancreatic cancer and, indeed, based on a recent study, far worse than conventional treatment.

From my perspective, it was incredibly bad timing and bad luck on Somers’s part to have one of the subjects she lionized in your book to have his protocol shown to be not just worthless, but likely actively harmful, a mere two months before the release of her book. In case there are any journalists who might be interviewing Somers and are interested in more than a puff piece that lets her promote her book, I list all the posts on Science-Based Medicine that have discussed the rank pseudoscience that is the Gonzalez protocol because, as many of you have figured out, I’m never satisfied with a hammer to smack down a form of woo when going nuclear is so much more fun:

Sadly, this bad timing appears to have had no effect whatsoever on the publicity blitz of an actress who every day tries to live down to the character she played on Three’s Company back in the 1970s or on the questions asked of her by interviewers. Somers has been all over the media this week, and I’ve seen nary a challenging question stronger than pointing out that some of the doctors featured in Somers’ book have gotten in trouble with their state medical boards, much less a much deserved question about Nicholas Gonzalez. Instead we’ve thus far been treated to cliched, credulous headlines like Suzanne Somers questions chemo in new book, Somers’ New Target: Conventional Cancer Treatment, or Suzanne Somers works to ‘Knockout’ cancer. The article circulating about her book on the AP wire begins:

Less than a year after the former sitcom actress frustrated mainstream doctors (and cheered some fans) by touting bioidentical hormones on “The Oprah Winfrey Show,” she’s back with a new book. This one’s on an even more emotional topic: Cancer treatment. Specifically, she argues against what she sees as the vast and often pointless use of chemotherapy.

Somers, who has rejected chemo herself, seems to relish the fight.

Let’s get one thing straight here. It is most definitely not, as implied by various articles about Somers, in any way amazing that Somers is still alive after having “rejected chemotherapy.” As I explained at the dawn of this blog, Somers had a stage I tumor with a favorable prognosis. If Somers is going to play the gambit of repeating, “I rejected chemotherapy and tamoxifen and I’m still alive” and attributing her survival to the alternative medicine woo she chose instead, perhaps now is the time to go into more detail than I’ve ever gone into before about her case. Well, not quite. I did go into quite a bit of detail in my talk at the Science-Based Medicine Conference at TAM7 in July. After all, I did the research; so I might as well get some more use out of it and spread it beyond the 150 or so people who heard my talk.

Prelude by flashback: Suzanne Somers’ breast cancer

In preparation for my talk at TAM7, I searched for all the information I could find that was publicly available about Suzanne Somers’ diagnosis of breast cancer back in 2000. For your edification, I’ve also uploaded the slides from my presentation relevant to Suzanne Somers’ breast cancer diagnosis as a PDF file. Suffice it to say, there is a great deal of misunderstanding of breast cancer in Somers’ testimonial. In this case, I don’t actually blame Somers all that much for her misunderstanding, because it is a very common misunderstanding that clearly derives from a misunderstanding of the difference between using chemotherapy for primary treatment of cancer versus adjuvant treatment of cancer. In early stage breast cancer, which can be surgically removed for cure, chemotherapy and radiation therapy are in general used as additional therapies that decrease the risk of recurrence of the cancer after surgery. That’s what adjuvant therapy is, extra therapy that improves a patient’s odds of surviving after a primary treatment. In the case of early stage breast cancer, the primary treatment is surgery.

From what I can find from publicly available information on the Internet (I’ve never read one of Suzanne Somers’ books), at age 54 Somers was diagnosed with a breast cancer that was treated by lumpectomy (excision of the “lump” or tumor) and a sentinel lymph node (SLN) biopsy, the latter of which was negative for tumor cells in the SLN, plus radiation therapy. For those not familiar with the SLN procedure, it is a procedure that developed in the 1990s to determine whether a woman’s breast cancer has spread to the axillary lymph nodes (the lymph nodes under the arm) without actually removing all of the axillary lymph nodes. Before the advent of SLN biopsy, the standard of care was to do an axillary dissection (removal of all the lymph nodes under the arm) on the side of the tumor in order to determine if and how many of the lymph nodes are positive for cancer. This is critical information, because the single most powerful prognostic indicator for potentially curable breast cancer (i.e., breast cancer that has not spread beyond the axillary lymph nodes to the rest of the body, such as bone, liver, or lung) is the presence of metastases in the axillary lymph nodes and, if they are present, how many. Unfortunately, as less invasive means of treating breast cancer were developed, such as lumpectomy, the part of the operation that carried the most morbidity was the axillary dissection. Consequently, as science-based physicians are wont to do, during the 1990s surgeons tried to find a way to get the same information (are the lymph nodes positive or negative) with a less morbid procedure and thus reserve axillary dissection only for patients who do have lymph nodes with breast cancer metastases in them.

Thus, the SLN biopsy was developed as a strategy to decrease the possibility of the most feared complication of axillary dissection, lymphedema, and still get the necessary information regarding lymph node positivity or negativity. Basically, an SLN biopsy is preformed by injecting both a radioactive dye and a blue dye (usually Lymphazurin Blue) into the breast. The dyes are then taken up in the lymphatics and head towards the axilla, where they lodge in one or more lymph nodes. This is (these are) the sentinel lymph node(s). The concept behind the procedure is that the sentinel node is the first lymph node a tumor cell that broke off from the tumor and got into the lymphatics will “see” and lodge in. In other words, the dye mimics the pathway that tumor cells take to metastasize to the axillary lymph nodes. If the sentinel node is negative, it’s an accurate indication that the rest of the lymph nodes are negative, and in general no further surgery is needed. Women are identified as node negative without removing all the axillary lymph nodes. Best of all, the risk of lymphedema from the procedure very, very small, far smaller than it is for axillary dissection (removing all the lymph nodes). Since the purpose of axillary dissection was far more diagnostic (to find out if the lymph nodes are contain tumor and, if so, how many), this is a good thing. On the other hand, if the SLN contains tumor, then axillary dissection is needed. In fact, far fewer women now undergo the procedure than in the past, and it is even coming under question whether a woman with a positive SLN truly needs a full axillary dissection.

Why do I mention this? Because I want readers to understand that Somers underwent, as far as I can tell, standard surgery for a favorable, estrogen receptor-positive stage I cancer. She also underwent radiation, although she has stated in the past and now states in Knockout that, if she had it all to do over again, she would not have opted for radiation. Be that as it may, she has been trumpeting proudly for a number of years that she rejected chemotherapy and tamoxifen and has done quite well. This claim, although true, says nothing about whether he decision to eschew those adjuvant therapies was a good one and even less about whether the woo she pursued after that had anything to do with her survival. As I described so long ago, however, surgical excision is curative for most small breast cancers. Radiation therapy reduces the risk of local recurrences (recurrences in the breast), and chemotherapy and antiestrogen therapy (like Tamoxifen) reduce the risk of systemic recurrences (recurrences elsewhere in the body). In other words, chemotherapy and radiation are “icing on the cake” after surgery. Indeed, there is a website known as AdjuvantOnline.com that allows physicians to calculate the estimated risk of recurrence and the estimated benefit of chemotherapy and, if appropriate, antiestrogen therapy. Given when Somers had her cancer diagnosed (2000) and because I know that she had a stage I tumor, i entered data for her assuming a tumor between 1-2 cm in size, mainly because most tumors under 1 cm would not warrant adjuvant chemotherapy. Here is a blowup of the key slide from my talk where I showed the results I got when I entered the known information about Suzanne Somers’ tumor into AdjuvantOnline:

Somers2a

(Click for a larger image.)

As you can see, based on what we know from publicly available sources, Somers had an 88.6% chance of living 10 years without any chemotherapy or Tamoxifen. Chemotherapy provides a survival advantage of 2.5%; tamoxifen, 2.5%; and combination therapy, 4.1%. In other words, eschewing chemotherapy and tamoxifen increased Suzanne Somers’ odds of dying of her cancer within 10 years by around 4%, not a huge number. As I’ve explained before, although the benefit of chemotherapy and tamoxifen for early stage breast cancer is around 30% on a relative basis, but it’s only around 4% or 5% on an absolute basis. You may think that’s not very much, but, I assure you, the vast majority of women are willing to undergo chemotherapy and hormonal therapy for that extra insurance. Indeed, I would point out that surveys I have seen have revealed that a majority of women would still opt for chemotherapy even if it provided only a 1% absolute survival benefit. Moreover, for more advanced tumors, that relative benefit generally stays around 30% or so, meaning that, as the risk of dying from cancer goes up, the absolute benefit of adjuvant chemotherapy goes up as well. Be that as it may, I’ve laid out this information to point out that testimonials like Somers’ are not particularly impressive if you know something about breast cancer. I also mention it to point out that, even though it’s a bad idea for Somers to be pumping herself full of “bioidentical hormones,” the favorable nature of her tumor means that she can get away with it. Even if it increased her risk of recurrence by 10 or 20%, the odds of survival would still be overwhelmingly in her favor, adjuvant chemotherapy and tamoxifen or not, thanks to her friendly neighborhood surgeon. So when you see a passage like this about Somers, remember what I’ve just told you:

Diagnosed with breast cancer a decade ago, she had a lumpectomy and radiation, but declined chemotherapy, as she did more recently when briefly misdiagnosed with pervasive cancer.

As I said before, Somers’ misunderstanding of the role of adjuvant therapy in breast cancer is somewhat understandable. It is a concept that can be difficult to communicate this to patients under the best of circumstances, and the absolute benefit of chemotherapy in treating a stage I ER(+) cancer is relatively small. Moreover, treatment paradigms change with new scientific evidence. Most women these days with a stage I ER(+) tumor would undergo Oncotype DX® testing, and the results of that testing would guide the decision of whether chemotherapy is recommended or not. Oncotype DX did not exist in 2000, and adjuvant chemotherapy was recommended for the vast majority of women with a stage I breast cancer with a tumor greater than 1 cm in diameter.

Somers’ second testimonial, however, is not as forgivable as the first, which is actually only somewhat forgivable, given how aggressively Somers has used her own testimonial to promote “alternative” medical treatments such as mistletoe extract (which may have some anti-tumor activity but the evidence is very weak–more on that perhaps in a future installment). It reveals such a profound ignorance of what she herself is recommending to women for their “health” that, as a breast cancer surgeon dedicated to providing only the best science-based surgical and medical care to my patients, I must call her out for it.

Knockout: Suzanne Somers’ “whole body cancer” scare

I do not yet have my promotional copy of Knockout, although, I’m assured, it’s on the way. I had debated whether to wait until I had read it to write about the book, but then last week I saw this interview with Ann Curry:

It was also pointed out to me that Chapter 1 of Knockout is available online at the Random House website. It’s entitled A Cancer Story–Mine. I read it and was appalled at the degree of misinformation being discussed right there in the very first chapter of the book, so much so that I started to doubt whether it was such a good idea of me to get a copy of the whole book and do a review on it. Still, I’m made of fairly stern stuff, and Somers is out there promoting the hell out of this book; so I feel that it’s my duty to look critically at the story she begins her book with. Suffice it to say, after I read Chapter 1, I was left shaking my head that anyone would listen to Suzanne Somers about cancer or any other health issue, so deep is the ignorance and so strong the distrust of “Western medicine.” Somers starts out her book by describing a cancer scare. Specifically, she describes an incident in which she was brought to the hospital with what sounds like an anaphylactic reaction of some sort and was misdiagnosed with what she calls “full body cancer.”

Before I go on, let me say right here that I do not mean to denigrate or otherwise downplay the seriousness of what happened to Somers, nor do I mean to cast doubt on the veracity of her story. At the very least, Somers appears to believe what she is saying, and it is quite possible that she was misdiagnosed with widespread metastasis from her breast cancer. I also don’t want to under estimate how much it probably scared her. Imagine yourself having survived breast cancer and then, eight years later, being admitted to a hospital for something else and being told that you had widespread metastases. It’s a horrible thing, if it really happened the way Somers said it happened, and it’s the sort of experience that would terrify anyone.

Color me somewhat skeptical, however.

Certain elements of Somers’ story sound a bit fishy. First off, Somers declines to identify the hospital. Right at the outset, I wondered why that is and can guess at a couple of likely reasons. First, perhaps she’s worried about being sued. Of course, if you’re a celebrity and the truth is on your side you probably don’t have much worry about being sued. In such a case, it’s far more likely that the entity suing would get the worst of it, at least as far as negative publicity. More likely, Somers knows that, whatever hospital she had been admitted to and whatever doctors had cared for her, patient confidentiality and HIPAA law prevent the hospital and doctors from discussing her case–or even admitting that Somers was ever a patient. Indeed, neither the hospital nor any of the health care professionals involved with Somers care can discuss her case without her explicit permission. Their hands are completely tied, and Somers can write and say whatever she wants without fear that anyone will contradict her. That’s why it disturbs me that no one who has interviewed Somers yet has asked her a handful of very obvious–and inconvenient–questions based on the anecdote in Chapter 1, namely:

  • At what hospital were you hospitalized and when?
  • Who were your doctors?
  • Will you release some of your medical records and allow your doctors to speak about your hospitalization?
  • If not, why not?

These are questions that need be asked in addition to questions about Somers’ support for Nicholas Gonzalez, whose pancreatic cancer “protocol” was recently shown to be worse than useless, but I have yet to see anyone ask her these questions.

Now, on to Chapter 1:

I wake up. I can’t breathe. I am choking, being strangled to death; it feels like there are two hands around my neck squeezing tighter and tighter. My body is covered head to toe with welts and a horrible rash: the itching and burning is unbearable.

The rash is in my ears, in my nose, in my vagina, on the bottoms of my feet, everywhere — under my arms, my scalp, the back of my neck. Every single inch of my body is covered with welts except my face. I don’t know why. I struggle to the telephone and call one of the doctors I trust. I start to tell him what is happening, and he stops me: “You are in danger. Go to the hospital right now.” I knew it. I could feel that my breath was running out.

Right off the bat, to me Somers’ symptoms sound like an allergic reaction to something or an anaphylactic reaction. It could be something else (more later), but the first thing that comes to mind is an allergic reaction. Indeed, upon hearing this story, I couldn’t help but wonder if one of the many supplements that Somers takes on a routine basis was the cause. Did she start any new supplements recently? Certainly I’d wonder about that. (Again, more on that later; my speculation may well have been correct, just not in the way I thought at first.) Regardless of the initial cause, it certainly sounded as though the E.R. docs at whatever hospital Somers was brought to thought she was having some sort of allergic reaction. Based on that, they treated her appropriately with Benadryl, Albuterol, and steroids. Even someone as medically ignorant as Somers realized the most likely diagnosis:

I say to the doctor, “It seems to me that I’ve either been poisoned or am having some kind of serious allergic reaction to something. I mean, doesn’t that make sense? The rash, the strangling, the asphyxiation. Sounds classic, doesn’t it?”

“We don’t know. A CAT scan will tell us. I really recommend you do this,” the doctor says. “Next time you might not be so lucky — you might not get here in time. You were almost out.”

As I read this part of the story, I was puzzled, and certainly Somers didn’t initially give enough information for me to hazard a particularly educated guess about why her doctor ordered a CT scan. After all, a CT scan is not generally the test of choice for diagnosing the cause of anaphylaxis or respiratory distress, which is what it sure sounds as though Somers was being treated for. On the other hand, maybe doctors saw a mass on chest X-ray (quite likely, as we will soon see). They may also have suspected a pulmonary embolus (PE), for which chest CT has supplanted the older test previously to detect PE, namely the V-Q scan. There may have been other findings on physical examination that suggested that a CT scan might be indicated. (There almost certainly were.) Again, initially, at least, Somers doesn’t give us enough information to judge. She does, however, engage in typical pseudoscientific thinking. While acknowledging that those evil pharmaceuticals had saved her life, still she can’t help but attack them:

I am now dressed in a blue hospital gown, and so far I’ve been reinforced by three rounds of oxygen and albuterol. I’m starting to feel normal again. Drugs have been my lifesaver this time. This is what they are for. Knowing the toxicity of all chemical drugs, I’ve already started thinking about the supplement regime and detox treatments I’ll have when I get out of here, to get all the residue of pharmaceuticals out of me. I’m hopeful this will be the one and only time I have to resort to Western drugs.

Remember, whenever you hear an alt-med maven say “Western medicine” (shades of Bill Maher!), what that alt-med maven is really referring to is science-based medicine. As for supplements, if they have anything in them that does anything physiological, they contain “chemical drugs.” There is no difference between “chemical drugs” found in pharmaceuticals and “chemical drugs” found in supplements, other than that the drugs found in supplements are adulterated with all sorts of stuff. There is no magical difference between the two. They both contain chemicals, and the body responds to chemicals through its biochemistry. Nothing makes supplements magically immune to the laws of physics and chemistry. Moreover, “detox” treatments are completely unnecessary quackery. Somers apparently doesn’t realize it, but her body is more than capable of “detoxing” away those evil “Western” pharmaceuticals through its own amazing abilities. Somers appears to think that “Western” pharmaceuticals somehow leave their taint behind. Maybe she thinks the cells in her body have a “memory” in the same way that homeopaths claim that water has “memory” and that the taint has to be somehow purged, just as a Catholic believes that confession purges sins or certain Muslim sects think that self-flagellation will purge them of their sins. It really is religious thinking more than anything else for Somers to think that she was somehow “contaminated” by “Western” pharmaceuticals and needed to have that “contamination” purged.

But I digress. So what did the CT scan find? This, apparently:

We have very bad news,” he continued. My heart started pounding, like it was jumping out of my chest. “You have a mass in your lung; it looks like the cancer has metastasized to your liver. We don’t know what is wrong with your liver, but it is so enlarged that it is filling your entire abdomen. You have so many tumors in your chest we can’t count them, and they all have masses in them, and you have a blood clot, and you have pneumonia. So we are going to check you into the hospital and start treating the blood clot because that will kill you first.”

We already know that Somers did not, in fact, have cancer. (Otherwise, it would not have been a misdiagnosis.) So what she did have, I’ll get to shortly. In the meantime, let’s take a look at what Somers says about her oncologist:

The oncologist comes into my room. He has the bedside manner of a moose: no compassion, no tenderness, no cautious approach. He sits in the chair with his arms folded defensively.

“You’ve got cancer. I just looked at your CAT scan and it’s everywhere,” he says matter-of-factly.

“Everywhere?” I ask, stunned. “Everywhere?”

“Everywhere,” he states, like he’s telling me he got tickets to the Lakers game. “Your lungs, your liver, tumors around your heart … I’ve never seen so much cancer.”

So the oncologist who saw Somers first was a world-class jerk. It’s quite possible. Not every doctor has a good bedside manner, and some have a horrendous bedside manner. Sadly, some of them are oncologists, even though, if there’s a specialty that really demands a good bedside manner, it’s that of medical oncologist. On the other hand, as physicians we have to remind ourselves all the time that what we think we have said to the patient is not always how the patient has heard it and how we come across to the patient is not always how we have, in fact, come across to the patient. Maybe the oncologist was that uncaring, maybe not. We have no way of knowing because all we have is Suzanne Somers’ report. Maybe it’s also true that the other oncologist who saw her was somewhat less of a jerk but just as quick to jump to a conclusion prematurely:

Then the lung cancer doctor enters the room. Maybe he has better news. But no—he says, “I just looked at your CAT scan, and you have lung cancer that has metastasized.” He is nicer, more thoughtful. “I mean, I’m going to think about this,” he says. “Maybe it’s something else, but this sure doesn’t look good. I’ll be back tomorrow.” Leslie takes out pen and paper and is making notes. She will continue to do this the entire week, writing down everything everyone is saying. Thank God, because when you are stunned and on medication, things get foggy.

Day one is almost over. The most shocking, devastating day of my life, our life! I know the facts: when you have lung cancer and it has metastasized to your liver, heart, abdomen, and all over your body, you have at most two months—maybe only two weeks or less.

As a possible bit of perspective, I’ll point out that not too long ago I had to relearn the lesson of how my perception of what I say to a patient may not always jibe with the patient’s perception of what I said. A while back, I saw a patient with breast cancer in her hospital room, a woman I had operated on the day before. I thought I had calmly laid out the situation, reassured her that her tumor was treatable, and told her that she might not need chemotherapy. About an hour later I got a frantic page from the floor. The patient was in tears, and the family was in an uproar. I don’t know how I had done it, but I had somehow given this patient the impression that her situation was hopeless and that she was going to die. When her family arrived to take her home she was crying. Apparently she had interpreted my telling her that she might not need chemotherapy (mainly because of her age and tumor characteristics) as telling her that it was pointless to treat her more. I relearned a valuable lesson that day, one I (and, I daresay, most doctors, no matter how experienced) need to relearn periodically, namely that patients don’t always interpret what I tell them the way I think they will and that sometimes how I view a conversation with a patient may be very different than how the patient viewed the conversation. Fortunately, I was able to reassure everyone and correct the misconceptions that had been left, but I did not feel too good about my bedside manner that day. In fact, the rest of that day I felt like the most insensitive, idiotic doctor in the world.

Or maybe Suzanne Somers’ oncologist was indeed a flaming jerk. That would be the worst case for “Western medicine” in this story, and it is not nearly as uncommon as I’d like to admit for a physician to have the personality of a paper cup or the bedside manner of bully. Besides, it’s easier to assume that that is how the oncologist in question treated Somers. Even so, in that case, I’d say, “So what?” I’m sorry that Somers’ oncologist treated her badly. There’s no excuse for that. I’d also tell her simply to go and get another oncologist or go back to her regular oncologist, which she ultimately did. One nasty doctor does not invalidate “Western medicine,” nor does the occurrence of a misdiagnosis, even one apparently this spectacular. In any case, it’s quite possible that there was a bit of Somers hearing things one way when her doctors weren’t telling it the way she interpreted them as telling her. The reason I say that is because Somers goes on and on, mainly in interviews but also in the book, about how, over six days, doctors told her she needed chemotherapy. As someone who has dealt with medical oncologists every day for over 10 years, that part of her story just didn’t seem very likely to me. The reason is that, in general, oncologists are very reluctant to administer chemotherapy to a patient in the absence of a definite tissue diagnosis proving that they have cancer, be it metastatic cancer or any cancer.

This would be doubly true in a case like what Somers describes in her book, particularly given that she had one oncologist thinking that she had lung cancer, not a recurrence of her breast cancer. In any case, widespread cancer could be a recurrence of her breast cancer (especially given Somers’ proclivity to pump herself full of “bioidentical hormones” after having been treated for an estrogen receptor-positive cancer), but in a 63-year-old woman, there are lots of other possible malignancies. Chemotherapy would be used for breast cancer might not work very well against, say, colon cancer or ovarian cancer, both of which are other likely possibilities in a woman of Somers’ age. Another reason I seriously question whether doctors were pushing hard for chemotherapy in a mere six days is because, if they truly thought she had such a massively widespread recurrence of her breast cancer, particularly an estrogen receptor-positive breast cancer, all treatment would be palliative. We can’t cure most metastatic solid tumors, and the first rule in treating stage IV disease is usually the classic “First, do no harm.” Thus, oncologists usually tend to do the minimum possible that it takes to relieve symptoms and (hopefully) slow the progression of the tumor. Most likely, if this was indeed metastatic breast cancer, an oncologist would have chosen to treat Somers first with an anti-estrogen drug, probably an aromatase inhibitor (no tamoxifen if she had blood clots causing that much trouble!) and then seen how she did. In the case of a woman who has ER(+) cancer recur as stage IV disease, that is almost always the first option. In such cases, chemotherapy is usually reserved for the case when antiestrogen therapy fails. Indeed, if the cancer was truly as widespread as Somers reports, chemotherapy might not even be used at all if the likelihood of success is tiny; in such cases, hospice would be recommended.

Be that as it may, the very first thing that any competent oncologist would demand before initiating chemotherapy is a tissue diagnosis, either from a needle biopsy or other tissue, to prove that there was cancer and to identify the type of cancer, so that the correct chemotherapy could chosen. Cancer chemotherapy is not like antibiotic therapy. In the case of infectious diseases, it is not uncommon to begin an antibiotic empirically based on the most likely organisms to be causing the infection and then to tailor the therapy to whatever organism(s) can be identified by cultures. Oncologists, on the other hand, are incredibly reluctant to treat metastatic cancer empirically, particularly cancer that appears to have recurred eight years after the original diagnosis of a stage I tumor. Such cancer might very well be a different cancer from a different organ, and the chance of doing harm with chemotherapy for no benefit is too great.

That’s why I thought right away that there’s something very fishy about Somers’ story. It just doesn’t add up very well. What I suspect to have happened is that perhaps the oncologist did have a conversation about a probable need for chemotherapy, and, like my conversation with my postoperative patient, Somers saw the conversation differently from how her doctors did. She probably viewed various “what if” scenarios or “if this is recurrent breast cancer, then you will need this” conversations as “pressuring” her to take chemotherapy. If her oncologist wasn’t particularly warm and fuzzy or patient, she might have been even more likely to interpret his recommendations that way. Or perhaps her oncologists were incompetent enough to pressure her to take chemotherapy without a diagnosis of biopsy-proven cancer. Who knows? Even if the latter is true, it still doesn’t excuse Somers’ horrible ignorance that becomes manifest later in the chapter.

Ultimately, Somers did get a biopsy. She describes it in her interview above, “They cut into my neck and went in and took a piece of my lung, a piece of one of the so-called tumors around my heart turned out it was not cancer at all.”

So what was it?

I’ll admit that my first guess, sarcoidosis, was dead wrong. Given the symptoms of skin lesions, shortness of breath, and, apparently, “tumors around the heart” (which could indicate either pericardial involvement, or, more likely enlargement of the paratracheal nodes), I didn’t think it too unreasonable a first guess. (Besides, in the cases in House, MD, sarcoidosis almost always appears on the differential diagnosis list.) However, never having lived in the southwest, having forgotten my medical school learning about common fungal infections, and being what I self-deprecatingly like to call a dumb surgeon, I didn’t consider what turned out to be the real diagnosis right away, namely valley fever, or, as it’s known by its official name, coccidioidomycosis. Indeed, the description of the most severe disseminated form of coccidioidomycosis matches Somers’ presentation quite well:

The most serious form of the disease, disseminated coccidioidomycosis occurs when the infection spreads (disseminates) beyond the lungs to other parts of the body. Most often these parts include the skin, bones, liver, brain, heart, and the membranes that protect the brain and spinal cord (meninges).

The signs and symptoms of disseminated disease depend on which parts of your body are affected and may include:

  • Nodules, ulcers and skin lesions that are more serious than the rash that sometimes occurs with other forms of the disease
  • Painful lesions in the skull, spine or other bones
  • Painful, swollen joints, especially in the knees or ankles
  • Meningitis — an infection of the membranes and fluid surrounding the brain and spinal cord and the most deadly complication of valley fever

Now here’s the kicker. Take a look at these two (out of several) risk factors for the most severe form of coccidioidomycosis:

  • Weakened immune system. Anyone with a weakened immune system is at increased risk of serious complications, including disseminated disease. This includes people living with AIDS or those being treated with steroids, chemotherapy or anti-rejection drugs after transplant surgery. People with cancer and Hodgkin’s disease also have an increased risk.
  • Age. Older adults are more likely to develop valley fever than younger people are. This may be because their immune systems are less robust or because they have other medical conditions that affect their overall health.

These are risk factors for the serious disseminated coccidioidomycosis. Most people who contract coccidioidomycosis are either asymptomatic or exhibit relatively mild symptoms. Indeed, valley fever often presents as a flu-like illness from which people recover rapidly. Many people, in fact, are unaware that they’ve ever had coccidioidomycosis until there’s either an abnormality on chest X-ray done for another reason or they have a positive skin or blood test. It’s very much like histoplasmosis right here in the Midwest. So why did Somers get such a serious case? It’s a legitimate question, given how she represents her regimen of supplements, bioidentical hormones, and various other woo as a highly effective path to rejuvenation and health that she recommends to her readers. Let’s see. Somers is 63, but apparently in good health. She also takes all sorts of supplements which, or so she claims, “strengthen the immune system.” But her immune system was obviously not strong enough to prevent her from getting disseminated coccidioidomycosis. Why didn’t all those supplements ward off the fungus? For someone who takes handfuls of supplement pills every day and makes millions of dollars selling woo to “boost the immune system,” Somers sure doesn’t appear to have a particularly strong immune system, as it failed miserably to protect her from a severe infection due to an endemic fungus that usually causes only mild disease or any symptoms at all but almost killed her.

Another possibility presents itself. As we know from her previous books and appearances on The Oprah Winfrey Show, Somers takes boatloads of “bioidentical” hormones. She promotes them as a fountain of youth for women. One wonders if any of her various supplements or bioidentical hormones were somehow adulterated with corticosteroids, which suppressed her immune system, one does. Or at least I do.

One need wonder no more. Right there, in Chapter 1 of her book, is a highly plausible, highly likely explanation for why Somers became as ill as she did from coccidioidomycosis:

Day 5. Dr. Oncologist comes into my room. Now, you would think he’d say, “Well, sometimes it’s good to be wrong.” Or “Isn’t it great that you don’t have cancer?” But no. He walks in, doesn’t sit down, just looks at me and says angrily, “Well, you should have told me you were on steroids.”

I am flabbergasted. I don’t know what to say to him; I am so stunned by his lack of compassion that I just stare at him. I am not on steroids. I would never take steroids. But because he is stuck in old thinking and so out of touch with new medicine, he has no clue and doesn’t understand cortisol replacement as part of the menopausal experience.

I don’t know where to begin with him. He’s too arrogant to listen to a “stupid actress,” anyway. So much of his attitude with me has been the unsaid but definite “So you think all your ‘alternatives’ are going to help you now, missy?”

Why steroids would have anything to do with being misdiagnosed with full-body cancer, I can’t guess. But we still don’t know what has gone wrong in my body. We still have to find out what caused me to end up in the ER.

(Emphasis mine.)

It’s incredibly hard at this point not to go even beyond Mark Crislip-grade acid sarcasm at the arrogance of ignorance on display. Here we have a woman who is apparently taking cortisol as part of her “bioidentical hormone” cocktail, and this woman does not know that each and every one of those estrogens she is taking is a steroid hormone. More importantly, Somers apparently does not know that cortisol is a corticosteroid (”cortico,” get it?), the very same kind of steroid that is routinely used by us evil reductionist practitioners of “Western medicine” as an anti-inflammatory and immunsuppressant. When used that way by us evil pharma shills, cortisol is known as hydrocortisone, which is–gasp!–a pharmaceutical concoction! It’s also “bioidentical,” too, proving once more that “bioidentical” does not mean “risk-free.” Indeed, hydrocortisone is often included as one of the drugs in immunusuppressive protocols used to prevent the rejection of organ transplants. Given that Somers has said that she takes enough “bioidentical” estrogens to recreate the hormonal milieu of a woman in her 20s (in other words, far more estrogens than a 63 year old woman would ever have or need), it’s not beyond the pale to wonder whether she similarly takes a significant dose of hydrocortisone (sorry, cortisol) as part of her brew of “bioidenticals,” particularly in light of her having fallen seriously ill due to an organism that usually causes mild disease in immunocompetent hosts. Yes, valley fever can sometimes be a bad disease in immunocompetent hosts, but being immunocompromised for whatever reason is still a significant risk factor for disseminated disease or the reactivation of quiescent disease.

After reading Somers’ story in Chapter 1, I shook my head in disbelief that Random House apparently didn’t have better editors who could have told Somers that she had just written something incredibly contradictory and just plain dumb when she wrote that didn’t take steroids in the context of writing how she castigated her oncologist for “not understanding” the role of cortisol in her menopause treatments. Also, based on Somers’ (or her ghostwriters’) own words in Chapter 1 of her book, I think I have discovered the most likely explanation for Somers’ contracting disseminated coccidioidomycosis. True, it could be that she was just unlucky and getting old, given that age is indeed a risk factor for disseminated disease, but one can’t ignore all the supplements she was taking. One can’t ignore that Somers was apparently taking cortisol as part of the cocktail of “bioidentical hormones” to recapture her youth. It is thus very reasonable to wonder whether the reason that Somers became so ill last year was because she had been chronically dosing herself with cortisol and suppressing her very own immune system. Worse, Somers doesn’t even understand that cortisol is a steroid and an immunosuppressant and therefore can’t accept or admit that this is a possibility. Indeed, that misunderstanding is leading her to view her misdiagnosis as clear evidence supporting her worldview that “Western medicine” is hopelessly flawed, chemotherapy rarely works, and the “alternative” medicine doctors whom she interviews can actually cure cancers that “Western” medicine cannot. Even worse still, Somers is successful enough to be able to parlay her suspicion into a highly lucrative career, and her promotion of dubious, unproven, and even ineffective medical treatments for cancer may well result in cancer patients who might be saved eschewing science-based medicine and endangering their lives. At least, that is what I fear.

A panoply of unproven treatments and what’s to come

As I said before, I plan on looking at Knockout and writing a more formal review once I get my copy to read. That’s why this post is labeled “Part 1.” However, so incensed was I at the rank pseudoscience and dangerous misinformation being promoted relentlessly over the past week by a woman who is apparently utterly ignorant of what a steroid hormone is or that steroids are immunusuppressive that I decided to do this post now, while Somers’ media blitz is still at its height. I concluded that an antidote to Somers’ promotion of nonsense such as the Gonzalez protocol needed to be provided in clear, concrete, unequivocal terms was needed now, that someone needed to express his opinion now that pseudoscience such as the Gonzalez protocol is quackery, particularly given the limp, woo-friendly response of Dr. Otis Brawley, chief medical officer for the American Cancer Society. His article, Somers’ cancer advice is risky, appeared on CNN.com. In it Dr. Brawley practically bent over backwards to be conciliatory, calling Somers a “wonderful actress” (she’s not and never has been), writing that he is “not critical of the concept of alternative and complementary medicine” (I am) and that “open-mindedness to other ideas is how we advance conventional medicine” (apparently his mind is so open that his brains threaten to fall out), even going so far as to invoke the hoary old alt-med examples of aspirin being derived from tree bark or vincristine being derived from a plant as though pharmacognosy were the same thing as herbalism. It’s not. Moreover, I wanted to provide a handy-dandy resource for journalists who may be interviewing Somers or people who may be seeing her at book signings or promotional events, hoping against hope that skeptics will ask her why she doesn’t think a steroid like cortisol wouldn’t predisopose her to disseminated coccidioidomycosis or why she thinks that Dr. Gonzalez is “curing cancer” when a clinical trial was published a mere two months before her book was released that showing clearly that his protocol is worse than useless and that pancreatic cancer patients undergoing conventional therapy live three times longer than those undergoing the Gonzalez protocol.

A guy can hope, can’t he?

In the meantime, here’s a chapter list, which will give you an idea of what you have to look forward to when I get around to reading the book:

The Doctors Who Are Curing Cancer
Chapter 5: Stanislaw Burzynski, M.D.
Chapter 6: Nicholas Gonzalez, M.D.
Chapter 7: Burton Goldberg
Chapter 8: Julie Taguchi, M.D.
Chapter 9: James Forsythe, M.D.

Preventing Cancer Before it Starts
Chapter 10: Russell Blaylock, MD
Chapter 11: Steve Haltiwanger, MD
Chapter 12: David Schmidt
Chapter 13: Jonathan Wright, M.D.
Chapter 14: Steven Sinatra, M.D., F.A.C.C., F.A.C.N.
Chapter 15: Michael Galitzer
Chapter 16: Cristiana Paul, M.S.

Most names I actually don’t know, but some names stand out, such as Dr. Burzynski, whom we haven’t yet discussed much on this blog but should (reviewing this book will give me just that opportunity), and Dr. Blaylock, who is best known for videos like this about H1N1:

I’ll spare you parts 2 and 3 of Dr Blaylock’s video. You get the idea, and if you are masochistic enough top want to view them, you can easily find them on YouTube. Suffice it to say, showing up on Alex Jones’ Prison Planet TV is not exactly a way to burnish one’s scientific credentials. Jones’ websites, Infowars and Prison Planet, are repositories of conspiracy craziness on par with David Icke’s lizard people, including 9/11 Truthers, “New World Order” conspiracy theorists (including, of course, the Illuminati and the Rothschilds), and a heaping helping of anti-vaccine and alt-med conspiracy mongering. In fact, Dr. Blaylock isn’t too far from David Icke’s rant about how the swine flu vaccine is a plot by the Illuminati.

Such are Suzanne Somers’ “doctors who are curing cancer.”

The bottom line is that, whatever her intentions, whether they be to help people or make money or both, Somers is unwittingly promoting dangerous cancer “cures” that are anything but cures. They are treatments that are anything but science-based, as well. Just as Jenny McCarthy, Jim Carrey, and Bill Maher are promoting anti-vaccine pseudoscience to the nation and Oprah Winfrey is providing an unmatchable soapbox for all manner of promoters of woo, Somers is taking advantage of her position to bash conventional medicine and promote non-science-based medicine, most likely raking in the cash hand over fist.

People may well die as a result.


[Slashdot]
[Digg]
[Reddit]
[del.icio.us]
[Facebook]
[Technorati]
[Google]
[StumbleUpon]

“Methodolatry”: My new favorite term for one of the shortcomings of evidence-based medicine

I’d like to thank revere right now publicly. He’s taught me a new word:

Methodolatry: The profane worship of the randomized clinical trial as the only valid method of investigation.

Many of you have e-mailed me and other SBM bloggers about a recent article in The Atlantic by Shannon Brownlee and Jeanne Lenzer, two reporters whose particular bias is that we as a nation are “over treated.” That may be true, although not to the extent that Brownlee, at least, seems to think, and her article on swine flu was truly biased and painful to read. Moreover, “methodalatry” perfectly describes one of the complaints we at SBM have about the “evidence-based medicine” paradigm. So I’m really glad that revere took it on and demolished it.

The hero of The Atlantic article, Tom Jefferson clearly has an agenda about flu vaccines. Indeed, he has such an agenda that he was invited to the National Vaccine Information Center’s vaccine conference in early October. The NVIC is the oldest and biggest antivaccine organization there is. Either he didn’t know that, in which case he’s clueless, or he didn’t care. In any case, it was clear that he was invited there because of his stance on flu vaccination, and he was even going to be awarded the NVIC “Courage in Science” Award. To his credit, Jefferson backed out when he found out that he would be sharing the stage with Andrew Wakefield, who was to be given the NVIC “Humanitarian Award.” He was appropriately horrified. Still, he should never have accepted in the first place, given that the NVIC clearly wanted to coopt him and use his gadfly status to make its anti-vaccine stance seem reasonable and science-based.

That’s just one reason why I don’t take Tom Jefferson particularly seriously anymore. I tend to agree with revere that Jefferson is drifting perilously close to crank territory with respect to flu vaccines. Indeed, “methodolatry” is an awesome term to describe his approach. Actually, it’s a great term to describe some of the Cochrane scientists responsible for analyzing the efficacy of mammography screening, as well; their conclusions and methods rather remind me of Jefferson’s.

Finally, you might also want to reread (or read for the first time if you haven’t read it already) Mark Crislip’s article on flu vaccine efficacy, which, although not directly written in response to Brownlee’s article, does address many of the shortcomings in its analysis of H1N1 vaccine efficacy.


[Slashdot]
[Digg]
[Reddit]
[del.icio.us]
[Facebook]
[Technorati]
[Google]
[StumbleUpon]

Maine’s Dirigo Health Savings One-Third of Original Estimate

Maine's Acting Insurance Superintendent, Eric Cioppa, ruled last Monday (17 September) that the Dirigo Health Program saved the health care system $32.8 million in its third year of operation; roughly only one-third of the original $92.7 million savings estimate released on 8 July 2007.

Despite Karynlee Harrington, executive director of the Dirigo Health Agency, previously stating in the Portland Press Herald that the agency had refined the methodology used to determine the savings amount based on past decisions of the superintendent, it appears the agency needs a new mathmagician in accounting.

On 27 July, the Dirigo Health Board of Director had reduced the estimated $92.7 million to $78.1 million.  The September 17 ruling of $32.8 million is the lowest savings figure, to date, in the agency's short, but beleaguered history; a possible indication that the agency has lost its steam.  Last year's savings were $34.2 million and the first year savings were ruled to be $43.7 million.

Of the $32.8 million, Cioppa found that the program provided $25 million in hospital savings, $6.3 million in uninsured and under-insured initiatives, and $1.5 million in provider fee savings.  The savings form the basis of the Savings Offset Payment (SOP), the sole funding mechanism for the program.

At a Dirigo Board meeting held after Cioppa's ruling, members discussed the possibility that the decrease in funding may result in the elimination of the subsidies currently paid to a majority of DirigoChoice program participants.

The Maine Dirigo Health program was established in 2003.  Dirigo stopped accepting new enrollees July 1, 2007.?

August a Flurry of Activity

I have to apologize for the abrupt shortage of articles in August, but the month was an absolute flurry of activity, behind the scenes.

In addition to maintaining BLOG Medicine, we operate a parent company (Maynard & Company) that provides healthcare consulting and management services.  Thanks to the steady increase in clients throughout New England, the services provided through Maynard & Company have transitioned to a new entity called Origin Health Group, recently taking on clients in the additional regions of the Mid-Atlantic and Deep South.  The stretch goal for 2008 is for Origin Health Group to have a presence coast-to-coast.

Also, after 11 months of brainstorming and hard work, we've created MedBay, the on-line auction community for healthcare equipment and services.  MedBay is wrapping up testing and is targeted for general release October 1.  Given the heightened awareness about health insurance and reform, MedBay will provide the ideal community mix for patient, provider, and purchaser.  I think MedBay will offer an exciting and attractive alternative to the current more restrictive and cost-prohibitive approach to paying for healthcare.  We'll be providing more information over the next few weeks as we approach our "go-live" date.

Finally, BLOG Medicine is evolving.  Over the next few months, BLOG Medicine will integrate into a larger blog platform that will include a mix of topics written by contributors from throughout the blogosphere.  Although my dedication hasn't changed, due to the other time commitments, my BLOG Medicine entries will now be biweekly on Mondays and Thursdays.  Bloggers interested in contributing to BLOG Medicine and/or the larger platform (including suggesting a name for it) are welcome to comment/contact me here.

Exciting times, indeed.  Expect BLOG Medicine to be back on schedule (and topic) with today's submission and watch for appropriate updates regarding MedBay over the coming weeks and [Insert New Blog Platform Name Here] over the coming months.  As always, I'd like to thank the readers of BLOG Medicine and especially those who have taken the time to comment -- we're nothing without you.?

New Orleans: Health Challenges

The Saturday, 4 August 2007 New Orleans Advocate reported that while the city is still facing the same significant healthcare needs and large racial disparities in health that existed prior to 2005's Hurricane Katrina, the storms also had a leveling affect across many health access and utilization measures, creating new access to care barriers for many still living in the region.

The basis for the article is the recently released report by the Kaiser Family Foundation, "Health Challenges for the People of New Orleans," that acknowledged that Katrina has made life more difficult for everyone in the area.

The Kaiser report is the result of a door-to-door survey of 1,500 residents in Orleans, Jefferson, St. Bernard, and Plaquemines parishes in Fall 2006.?

Dirigo Health: Con Artists, Liars, and Thieves?

With no new enrollment as of July 1 and stated savings estimates and membership numbers gyrating up and down faster than a turkey trot, one has to wonder if Maine's Dirigo Health is made up of con artists, liars, and thieves or if they actually believe their mathmagical accounting.

On 8 July 2007, Dirigo Health released a 2006 estimated savings amount of $92.7 million.  By Friday, 27 July Maine's Dirigo Health Board of Directors had reduced the amount they claim the Dirigo Health program has saved the state's healthcare system in 2006 to $78 million, still more than twice the amount determined in 2005 that required a ruling by the State Supreme Court to be settled.  The recently reduced $78 million figure will now be submitted to the state superintendent of insurance, who has historically reached a lower number than the board, for final determination.

Karynlee Harrington, executive director of the Dirigo Health Agency, was quoted in the Portland Press Herald stating that the agency has refined the methodology used to determine the savings amount based on past decisions of the superintendent seemingly oblivious as to why it should be objectionable that Dirigo's accounting methodologies are changeable, year-to-year and seem to conveniently eliminate Dirigo's earlier cost concerns.  However, not only do Dirigo's accounting methodologies change based on the needs of the day, but the membership numbers experience dramatic unexplained leaps, as well.

On 1 July 2007, when Dirigo stopped accepting new enrollees stating cost concerns, they quoted membership of 14,400, many of whom already had insurance and less than half of the 31,000 Dirigo said they would cover in 2003 and nowhere near the 130,000 Dirigo forecast for coverage by 2009.  By 28 July 2007, only 27-days after halting enrollment, Dirigo mathmagically claims 26,000 Maine residents have been helped.

For their part, as expected, Maine insurance carriers plan to dispute the board's figures, adding that it's a conflict of interest for the Dirigo board to make a determination on savings that will translate into income for its program.

Dirigo's annual attempt to be more than just another failed attempt at healthcare reform with lingering delusions of grandeur is similar, in its own way, to the frivolousness, fantasy, and mathmagical fiction that might be found in a Harry Potter book -- too bad, unlike JK Rowling, Dirigo doesn't know when to end the fairy tale.? 

Lifespan and Care New England Plan Monopoly (Again)

For the second time in ten years, Lifespan and Care New England, Rhode Island's two large health systems, plan to merge into a single entity to be called Lifespan.

In 1998, the two entities applied for regulatory approvals needed to merge, but pulled their applications in 2000.  If allowed to combine, the resulting entity will control nearly three-fourths of Rhode Island's hospital system.

Lifespan President and CEO George Vecchione expects this regulatory process to only take six to nine months and for the merger to result in some efficiencies, specifically in central-office operations and alignment of system-wide services, but without substantial job cuts.

According to Lifespan, clinical enhancements that would occur under the merger include:

  • Butler Hospital will create the state’s first Brain Sciences Institute, which will support research, education and behavioral health treatment. In addition, the Butler campus would be sold or otherwise developed to fund a new Butler Hospital facility on or near the RIH campus
  • Kent Hospital will apply to become a level II trauma center and will also seek to create an emergency medicine residency program. Together, these improvements will enhance statewide disaster responsiveness
  • Women & Infants will retain its leadership role in neonatal and women’s reproductive health. There will also be a greater opportunity to develop services for conditions that disproportionately affect women and to maximize Women & Infants’ referral network and strong regional presence
  • Continuation of Care New England’s VNA under the Lifespan system

Mixed responses to the merger plans include Rhode Island Governor Donald L. Carcieri (R-RI) who notes that the creation "of such a dominant healthcare network" raises "a number of important concerns" and  Lt. Governor Elizabeth H. Roberts, who states that she will "advocate for a focus on the core mission of hospitals to serve the public and recognize the importance of this proposal’s potential for economic growth in the state.”?

Mass Governor Asks Blue Cross to Keep Higher Employer Contribution

At the request of Governor Deval L. Patrick (D-MA), the state's largest health insurer, Blue Cross and Blue Shield of Massachusetts, scrapped a new policy that would have allowed owners of small businesses to contribute just one-third of the cost of their employees' health plan premiums.  Blue Cross is the state's largest health insurer with about 3 million members.

Prior to 1 July, Blue Cross required a minimum 50 percent contribution to premiums from employers with 50 or fewer workers.  The average contribution by Massachusetts employers is about 75 percent.

On 1 July, Massachusetts's healthcare reform law took effect, under which, if a company does not offer health insurance, low income works can receive subsidized coverage under the state's Commonwealth Care plan.  They are ineligible for assistance, however, if their employer offers a company health plan, regardless of the company's contribution to premiums.

Company's not offering health insurance to their employees or contributing less than what the state deems "fair and reasonable" toward their employees' health plan premiums are required to pay an annual fee of $295 per employee.

Harvard Pilgrim Health Care, the state's second largest health insurer with about 1 million members, has said that the insurer will retain its 50 percent contribution after earlier reviewing its policies as a result of Blue Cross's lowering its minimum contribution to 33 percent.?

AMA Sounds the Alarm, Medicare Making Yet Another Attempt to Cut Reimbursement

The American Medical Association (AMA) must once again don its armor, this time preparing to go to battle on behalf of its approximately 240,000 members over pending cuts to Medicare reimbursement.  Physicians received below-inflation updates in 2004 and 2005 and zero percent updates in 2006 and 2007.

Without congressional action, Medicare physician payment rates will be reduced 10 percent effective 1 January 2008.  By 2016, the cuts will total about 40 percent, while practice costs are expected to increase by 20 percent.

In addition to steep pay cuts, the AMA charges that the Medicare physician payment update formula:

  • has kept average 2007 Medicare physician payment rates about the same as they were in 2001
  • prevents physicians from making needed investments in staff and health information technology to support quality measurement
  • punishes physicians for participating in initiatives that encourage greater use of preventive care in order to reduce hospitalizations
  • has led to a severe shortfalls in Medicare’s budget for physician services that have driven Congress to enact short-term interventions with funding methods that have increased both the duration of cuts, as well as the cost of a long-term solution
  • hurts access to care for America’s military families, has payment rates in the Department of Defense’s TRICARE program are tied to Medicare rates

An AMA Physician Payment Action Kit is available for more information and the AMA Physician Grassroots Network to receive updates on physician payment rate legislation.

The impacts of Medicare physician payment cuts in New England are significant:

  • New England physicians will lose $306 million for the care of elderly and disabled patients in 2008 due to the 10 percent cut in Medicare payments beginning 1 January.  The region's physicians will lose $12.1 billion for the care of elderly and disabled patient by 2016 due to eight years of cuts
  • 149,461 employees, 2,007,382 Medicare patients and 234,343 TRICARE patients in New England will be affected by these cuts
  • 42 percent of New England's practicing physicians are over 50, an age at which surveys have shown many physicians consider reducing their patient care activities

CT

ME

MA

NH

RI

VT

Losses in 2008

$92 million

$27 million

$137 million

$22 million

$18 million

$10 million

Losses by 2016

$3.7 billion

$1 billion

$5.4 billion

$860 million

$720 million

$380 million

Affected:

  Employees

39,803

13,671

63,187

14,144

11,613

7,043

  Medicare Patients

485,970

220,081

884,894

170,937

155,540

89,960

  TRICARE Patients

51,403

46,849

70,159

28,786

24,818

12,328

Physicians Aged 50+

42%

46%

38%

43%

37%

43%

  • Compared to the rest of the country, Connecticut, Massachusetts, Rhode Island, and Vermont, each at 14%, has an above-average proportion of Medicare patients
  • Compared to the rest of the country, Maine, at 17%, has the second highest proportion of Medicare patients and, at 17 practicing physicians per 1,000 beneficiaries, has a below-average ratio of physicians to Medicare beneficiaries, even before the cuts take effect
  • In 2008, on top of the 10 percent cuts across the country, the "Southern Maine" Medicare payment area faces cuts of an additional 1.1 percent, the "Rest of Maine" Medicare payment area faces cuts of 2.1 percent; New Hampshire faces cuts of an additional 1 percent; and, Vermont faces cuts of an additional 1.7 percent

Countering the congressional inaction and the resulting 10 percent rate cut, the AMA is advocating a 1.7 percent increase in reimbursement in 2008, in line with the estimated practice cost increase; long-term, the AMA wants Congress to create a new reimbursement formula.

Over-stepping their role as a payment mechanism and forgetting that they're not actually providers of medical care, the talking-heads of the health insurance industry charge that physicians are partly to blame, contributing to costs by ordering unnecessary and expensive services.  Mohite Ghose, spokesman for the insurance trade association, America's Health Insurance Plans, was even disingenuous enough to question whether physicians are always providing "appropriate services at the right setting at the right time."

BLOG Medicine must concur with the AMA's statement that, "utilization of physician services is not the cause of the Medicare program's financial predicament, and cuts in physician payment rates are not the way to improve Medicare's financial sustainability."  Congress needs to bring up the house-lights and call a close to this "annual dance of death" -- it's time to pay the piper.?

Pollyanna With a Pen: Maine Governor Signs 18 New Health Care Bills into Law

On Tuesday, 17 July, Governor John Baldacci (D-ME), joined by the state's legislative Democrats, signed into law 18 new health care bills meant to protect the health and welfare of the people of Maine.

You couldn't see the rose-colored glasses on his face, but Baldacci's "Pollyanna" was definitely showing in his prepared statement: "What all these have in common is that they provide further evidence that Maine is the leader in health care reform and in efforts to expand access to quality, affordable health care."

Maine, already heavily burdened with healthcare legislation, has added laws that require health insurers to extend coverage to policy-holder's adult children until age 25, to require health insurers to cover hearing aides, to prohibit advertising of prescription drugs on software sold in Maine, to ensure sterile supplies for needle exchange programs, and to regulate access and screening for HIV and cancer.

Increasing health care costs, postpartum depression, eating disorders, and the role of dental hygienists are all to be reviewed by study groups.  November will be Lung Awareness Month, Free Health Clinics will have lower taxes and, disturbingly, despite widely being viewed as an expensive failure and having stopped accepting new enrollees as of 1 July due to cost concerns, Dirigo Health will now be allowed the even more expensive proposition of self-insurance.

Noticeably absent from Tuesday's "Glad Game" shenanigans was a resolution for the much-needed reform to MaineCare, Maine's overloaded and very broken Medicaid program and a new, functional, self-supporting funding-mechanism for Dirigo Health.

The Maine Legislative Documents signed into new law include:

LD 4 -- An Act to Amend the Prescription Privacy Law

LD 101 -- An Act to Enhance Screening for Breast Cancer

LD 144 -- An Act to Support Maine's Free Clinics

LD 243 -- An Act to Establish November as Lung Cancer Awareness Month

LD 429 -- An Act to Improve Access to HIV Testing in Health Care Settings

LD 431 -- An Act to Enable the Dirigo Health Program to be Self-Administered

LD 792 -- An Act Concerning Postpartum Mental Health Education

LD 807 -- An Act to Prevent Overcharging for Prescription Drug Copayments

LD 839 -- An Act to Establish a Prescription Drug Academic Detailing Program

LD 841 -- An Act to Extend Health Insurance Coverage for Dependent Children up to 25-Years of Age

LD 995 -- An Act to Reduce the Expense of Health Care Treatment and Protect the Health of Maine Citizens by Providing Early Screening, Detection and Prevention of Cancer

LD 1044 -- An Act to Address Eating Disorders in Maine

LD 1129 -- An Act to Increase Access to Oral Health Care

LD 1440 -- An Act to Prohibit Inappropriate Software Advertising of Prescription Drugs

LD 1514 -- An Act to Require Health Insurance Coverage for Hearing Aides

LD 1786 -- An Act to Reduce the Spread of Infectious Disease through Shared Hypodermic Apparatuses

LD 1812 -- Resolve, Regarding the Role of Local Regions in Maine's Emerging Public Health Infrastructure

LD 1849 -- An Act to Protect Consumers from Rising Health Care Costs.?

For an Operator, Please Press…

We've all experienced it -- calling customer service only to be put on never-ending hold, or, worse, having to listen to the numerous prompts, pressing all the appropriate keys only to be disconnected.

Paul English, founder of Gethuman.com, figured out a better way.  He and his core group of supporters tracked down and have published the shortcuts that cut out the computerized telephone middle-man and get you to a human operator.

English's site allows you to jump to specific categories (e.g., Insurance) as well as sort individually through the more than 500 companies to find both toll-free telephone numbers and the shortcuts that get you off hold and connected to a live person.  The site also has a link if you prefer a printer-friendly format rather than electronic version of the information.

In a corporate world dominated by impersonal, unhelpful, computerized interactive voice response, English's site is much-needed relief for an all-too-human frustration.?

Health Insurance Benefit Costs by Region

According to March 2007 data released by the U.S. Bureau of Labor and Statistics, among the four regions of the United States, the average cost per hour to employers for health insurance benefits ranges from $1.59 to $2.04.

Employer costs per hour worked for health insurance by region, private industry, March 2007

The Compensation Cost Trends program reports that the proportion of total compensation represented by health benefits was 6.7 percent in the West, 6.9 percent in the South and Northeast, and 7.8 percent in the Midwest.

Nationwide, the average cost for health benefits was $1.83 per hour worked, accounting for 7.1 percent of total compensation.?

Why No One Will Talk About “Cloud Computing” in 10 Years

Kevin HazardAt the 2009 Cloud Computing Conference in Santa Clara, Calif., The Planet Director of Product Management Rob Walters was one of five experts invited to participate in a panel discussion about enterprise-level cloud computing – whether it’s a far-off dream or a present-day reality. Conference Chair Jeremy Geelan covered everything from whether the term “cloud” was too broad to be useful to whether private clouds and public clouds can coexist.

I caught up with Rob in the expo hall to have him weigh in on each of the questions for our loyal blog readers (you!):

I love the analogy he uses to explain why “the cloud” is such a difficult concept to explain. It seems to be a paradigm shift unlike any we’ve seen in recent memory, so the transition from hype and confusion to understanding and adoption should prove to be an interesting adventure over the next few years.

One of the most interesting questions asked of the panel was whether or not we’d be talking about cloud computing in 10 years. The unanimous answer: No. Why? The resounding sentiment is that shift toward “the cloud” will be so pervasive that a given platform’s “cloudiness” will be implied. This opinion is shared by a group of experts at a “cloud computing conference,” so there may be a little bias here … What do you think? Will the cloud take over and become the de facto standard or will demand for traditional IT remain in the midst of the cloud’s surge?

-Kevin

StumbleUpon
Twitter
DZone
Digg
del.icio.us
Technorati

Boo Bash 2009 – Desktop Costume Included!

Kevin HazardSince Halloween falls on a Saturday this year, The Planet’s annual Boo Bash is happening today. As you can see from our archives, there are a lot of creative people around here, and when a costume contest challenge is issued, you’re bound to get some interesting results. I’ve already seen a fully costumed Ghostbuster, a bumble bee, and about 45 people – including our CEO and CFO – dressed as Todd Mitchell. They say imitation is the sincerest form of flattery, so Todd must feel VERY flattered.

We will post our costumed competitors on The Planet Flickr for all to see, and you can post a comment here to vote for your favorites. Click the picture of “Todd” below to go directly to the Boo Bash 2009 album.

Todd Mitchell

To let you share in today’s costuming, we’ve got a present for you. As a part of our fundraising efforts to support the American Heart Association, we printed shirts for employees who donate. The shirt design has been so popular internally that I made it into a few wallpapers that you can use:

You Got Served

Versions Available:
Dual-Monitor Setup (2560 x 1024)
Single Monitor – Server Only (1280 x 1024)
Single Monitor – “You Got Served” Only (1280 x 1024)

After you get your desktop suited up in its new costume, remember to vote for your favorite Boo Bash 2009 entrant in the comment section below.

Trick or Treat!

-Kevin

StumbleUpon
Twitter
DZone
Digg
del.icio.us
Technorati

Know Thy Backups – Part II

Ben KeenerIn Know Thy Backups – Part I, we started discussing the most common strategies of backing up your data, and before we continue that discussion, I should clarify that we’re not talking about hardware configurations like RAID or backup products like Evault and Data Protection Servers. These backup schemes can be executed without spending a dime on additional equipment or resources. While there are best practices and recommendations for making backups and keeping them safe, if your budget is limited, you can protect and preserve your data using one of these schemes on your local workstation or on a secondary drive in your server.

When we looked at the full server and simple incremental backups in our previous post, we noticed a significant limitation: losing a single backup can be catastrophic to restoring data. In the next two schemes, we’ll evaluate solutions that protect us from this vulnerability.

Differential Incremental Backups

A differential scheme requires a full backup reference point and then makes a backup of all changes to the server from that reference point on each subsequent backup. This method requires more storage space than incremental backups but generally doesn’t need as much space as a full backup.

Based on the volume of changes made between the first backup, the reference point and the current backup, differential incremental backups may require additional server resources than an incremental backup. Simple and multi-level incremental backups constantly update the reference point with minimal load, while differential backups update the reference point with a new full backup.

Example: Differential Incremental Backups

As in the previous example, I am using a schedule of backups that starts with a full backup on Sunday, with additional backups on the following days. This time, I’m using differentials. Let’s say that on Thursday I find some inconsistencies in the database when compared to the paper files I received from a vendor. After investigating, I find that my database is corrupted. I determine that I will not be able to recover the database as it is, so I review my backups.

Somehow, I cracked the DVD that my Tuesday backup was stored on, but all of the other discs are here. I start by restoring the Sunday backup and then the Wednesday backup, hoping the corruption occurred after the backup was made. Thankfully, the restoration works, and we are up and running again after losing minimal data. If I had been using simple incremental backups, I would have been able to restore only up to Monday because Tuesday’s backup disc was broken.

Multi-level Incremental Backups

There’s a more granular and robust backup scheme that is less vulnerable than simple incremental backups and less server-intensive than differential backups: The multi-level incremental backup. Multi-level increments assign a level to each backup and then make a comparison against the last lower-level backup made. Only the changes between the reference point and the current data are saved.

This arrangement allows you to design a backup scheme around your needs and the capabilities of your server, and you can decide how many backups you will need for a full restoration to the latest restore point. You will control the number of backups required for a given restore by determining the number of levels in the system. In the event of a disaster, you need a single backup of each level, and each higher level backup must use the lower level as its reference point.

Example: Multi-Level Incremental Backups

This time I am in charge of a Sendmail server that is always under heavy stress. Because this server is extremely important to my business, I need to ensure both its availability and responsiveness at all times. I also need to maintain archives of the e-mail on the server. To do this, I decide to implement a multi-level incremental backup scheme since I need more granular backup configuration that does not generate a great deal of load on the server. This scheme meets that need. It still retains the weakness of incremental backups, but I partially mitigate those weaknesses with scheduling.

At the first of every month, a full backup is scheduled. This is my Level 0 backup, and it is named level0.name of the month. The following day I run a Level 1 backup. This backup holds only the changes since the most recent Level 0 copy called level1.first.name of the month. The subsequent days of that week, I create a Level 2 backup called level2.first.day of the week.name of the month. This process continues until the Sunday after the first Level 2 backup.

On the next Sunday, I make another Level 1 backup called level1.second.name of the month. The subsequent days of that week, I make Level 2 backups called level2.second.day of the week.name of the month. I continue in this vein with every Sunday being a Level 1 backup and the rest of the week being Level 2 backups until the end of the month. On the first day of the next month, I start all over with another Level 0 copy.

I make certain to save multiple copies of the files after I test the archive. I also check to be certain it’s not corrupted, to minimize the risk of data loss through a faulty archive. This scheme allows me to restore to any point within the month in just three steps, as long as all of the archived backups work.

If I need to restore the data from April 17, 2009, I would need the archives for level0.april, level1.third.april, and level2.friday.third.april. I would restore them in sequence from Level 0 to Level 1 to Level 2.

Choosing Your Backup Scheme

As I said in the beginning of this post, these backup schemes are available to you without the use of an additional server or any expensive backup management software. All of the above are viable options for making your backups; however, not every scheme is perfect for every situation. You should review your requirements and the available resources to determine which scheme best fits your needs.

-Ben

StumbleUpon
Twitter
DZone
Digg
del.icio.us
Technorati

Know Thy Backups – Part I

Ben KeenerMore often than not, server backups are misunderstood. With dozens of hardware options and hundreds of software options, finding the right backup can be intimidating. To assuage some of those fears and clear up a bit of that confusion, let’s go over a few of the most common backup schemes. This list isn’t all-inclusive, and the options presented shouldn’t be mistaken for backup plans. A backup scheme is simply a method of creating backups. A backup plan (or disaster recovery plan) is a scheduled implementation of a backup scheme. As we evaluate each scheme, we’ll look at the requirements, costs and benefits, and by the end of our tour, you can decide which best fits your business.

Before we get too far into the specifics of the different schemes, we should define some fundamental terms that we’ll use throughout the comparison:

  • An archive is a set of data that is being preserved
  • A reference point is a single archive against which comparisons are made
  • A restore point is the most recent working backup

The key question a backup scheme answers is this: “If a server suffers a catastrophic failure, what is needed to resume operations with minimal downtime and data loss?” Again, the backup scheme is not a complete disaster recovery plan — its focus is the restoration of data.

The four basic backup schemes we’ll compare are full-server backups, simple incremental backups, multi-level incremental backups and differential incremental backups. The primary considerations about the method that should be used are the server load generated by the backup process, the backup file size, and the speed with which a backup can be restored.

Full Server Backups

A full server backup is one of the simplest methods for a backup scheme. It takes only a single backup archive to create a restore point, which makes data restoration simple and fast. The drawbacks are the amount of time it takes to make the backup, the load it generates, and the total size of the backup. Each backup scheme we’re comparing uses a full backup of the server.

As we evaluate the other schemes, you’ll note they all start with a full backup as a reference point, and create their own restore points as they move forward.

Simple Incremental Backups

A simple incremental backup attempts to resolve some of the issues with full backups, and it does a good job. With an incremental backup, a single full backup is made that serves as both a restore point and the initial reference point. On subsequent backups, it becomes a little more complex. Instead of making a new full backup when it is updated, this scheme compares the current state of the server against the state of the server as it was in the reference point (the first full backup). If it locates any changes, it backs up those changes and generates a new snapshot of the drive as another reference point. This new reference point is then used for the next incremental backup.

This backup structure means the restore point on a server with this backup will consist of the initial reference point and all subsequent incremental backups that use this reference point. This dependency is the primary weakness in simple incremental backups: All of the backups — from the original reference point to the incremental additions recording changes from the reference point — must be uncorrupted and complete for the backup to fully restore the data. If any backup is missing, corrupt or incomplete, the restoration can’t be completed.

The server load created and storage space required for this type of backup is generally less than what you’ll see in a full backup scheme, especially when there aren’t many differences between the backup point and the reference point. On the other side of the spectrum, if the entire data set changes between backups, the storage requirements and server load will be the same as they were when full backups were being performed.

Example: Simple Incremental Backups

I am implementing incremental backups for a database that houses all of my users’ data. I decide I am going to start with a full backup each Sunday — the slowest day of the week for the database — and do an incremental backup on each subsequent day. This process starts over again every Sunday. On Friday, my server suffers a catastrophic hard drive failure. I am told by the technician who replaced the drive that the controller failed, and the heads were idly tapping the side of the drive cage. Everything on the drive is lost.

I gather my backups and begin to restore them on the new replacement drive. The backups from Sunday, Monday and Tuesday restore without a hitch, but Wednesday’s backup is corrupted and will not complete. This means I have lost all of the data from Wednesday and Thursday. Without Wednesday’s backup, the rest of my incremental backups are useless.

There are two incremental backup schemes that attempt to address this issue: the differential and the multi-level incremental backup schemes. In Part II of “Know Thy Backups,” we’ll explain the pros and cons of these methods, and you’ll be ready to plan your backup strategy.

-Ben

StumbleUpon
Twitter
DZone
Digg
del.icio.us
Technorati

Disruptive Technologies: Virtualization and The Cloud

Todd MitchellIf you weren’t able to attend the cPanel Conference 2009 last week in Houston, you missed out on a great show. With all the networking events, educational sessions and vendor booths to visit, it was pretty tough to keep up as a participant, so the cPanel team deserves a high-five or two —physical or virtual — for having everything so well prepared.

As you may have heard, I led a session about “Disruptive Technologies: The Road from Disruptive to Sustaining.” Instead of copying the bullet points from my presentation into this blog post, we recorded the whole session on a Flip MinoHD. If you’ve got a little time and you’re interested to hear my take on the effects of the Cloud and Virtualization on hosting, go grab a bag of popcorn, turn up your computer speakers, sit back and enjoy:

media
[See post to watch the Flash video]

I opened the floor for Q&A in the session and for additional follow-up after the session after we ran out of time, so I want to do the same for you: When you watch the video, if you’ve got any questions, please post them in a comment below and I’ll be happy to respond.

-Todd

StumbleUpon
Twitter
DZone
Digg
del.icio.us
Technorati